🇺🇸 FDA
Patent

US 11045535

Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same

granted A61KA61K2039/53A61K2039/884

Quick answer

US patent 11045535 (Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same) held by Inovio Pharmaceuticals, Inc. expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inovio Pharmaceuticals, Inc.
Grant date
Tue Jun 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/53, A61K2039/884, A61K39/00, A61K39/0011